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BACKGROUND: The aim of this study was to examine trends of Down syndrome (DS) in relation to mater-
nal age and termination of pregnancies (ToP) in 20 registries of the International Clearinghouse for Birth
Defects Surveillance and Research (ICBDSR). METHODS: Trends of births with DS (live-born and stillborn),
ToP with DS, and maternal age (percentage of mothers older than 35 years) were examined by year over a
12-year period (1993–2004). The total mean number of births covered was 1550,000 annually. RESULTS: The
mean percentage of mothers older than 35 years of age increased from 10.9% in 1993 to 18.8% in 2004. How-
ever, a variation among the different registers from 4–8% to 20–25% of mothers >35 years of age was found.
The total mean prevalence of DS (still births, live births, and ToP) increased from 13.1 to 18.2/10,000 births
between 1993 and 2004. The total mean prevalence of DS births remained stable at 8.3/10,000 births, bal-
anced by a great increase of ToP. In the registers from France, Italy, and the Czech Republic, a decrease of
DS births and a great increase of ToP was observed. The number of DS births remained high or even
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increased in Canada Alberta, and Norway during the study period. CONCLUSIONS: Although an increase in
older mothers was observed in most registers, the prevalence of DS births remained stable in most registers
as a result of increasing use of prenatal diagnostic procedures and ToP with DS. Birth Defects Research
(Part A) 88:474–479, 2010.  2010 Wiley-Liss, Inc.
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INTRODUCTION
The incidence of Down syndrome (DS) at conception is
highly dependent on maternal age (Lindsten et al., 1981;
Hecht and Hook, 1996; Olsen et al., 1996; Bray and
Wright, 1998). Carothers and co-workers (1999) con-
cluded, based on data from 49 population groups, that
variation between population groups was small, after
accounting for maternal age. The majority of observed
differences in the prevalence of births with DS between
populations are thus likely to be due to variations in
maternal age distributions, maternal age-specific preg-
nancy rates, and the use of prenatal diagnosis and the
termination of affected pregnancies.
The International Clearinghouse for Birth Defects Sur-
veillance and Research (ICBDSR) is an international orga-
nization of population- and hospital-based registers for
surveillance and research of birth defects (Botto et al.,
2006). We assessed the impact of changes in maternal age
and the use of prenatal diagnostic procedures and elec-
tive terminations on the prevalence of DS at birth. Data
for this study came from the ICBDSR for the period
1993–2004, which comprises 20 registries in nine Euro-
pean countries and five non-European countries.
MATERIALS AND METHODS
Data were provided by 20 birth defects registers (Table 1)
from 14 countries (Australia, Canada, Czech Republic,
England, Finland, France, Israel, Italy, Mexico, the Neth-
erlands, Norway, Sweden, USA, Wales). Six registers
(Czech Republic, England, Finland, Norway, Sweden,
and Wales) covered all births in the nation, and the other
14 registers covered all births from a defined region in
their country. France and Italy reported data from three
and four different regions, respectively.
The following data were obtained from each registry
by year 1993–2004: total number of births, percentage
of mothers older than 35 years of age at delivery,
number of children (live-born and stillborn) with DS
per 10,000 births, number of terminations of pregnan-
cies (ToP) with DS per 10,000 births, and total number
of live-born, stillborn, and ToP with DS per 10,000
births. The overall means and percentages are pre-
sented as weighted means according to number of
births per country (Table 1).
Mean gestational age in weeks at termination for DS in
mothers >35 years of age in 2002 was available for 16 of
the registers (Table 2).
Table 1
Mean Number of Births; Percentage of Mothers Older than 35 Years; Mean Number of DS/10,000 Births; Mean
Number of Terminated Pregnancies with DS (ToP)/10,000 Births; Total Number of DS (Liveborn 1 Stillborn 1
ToP)/10,000 Births for the Period 1993–2004
Country/registry No. Births Maternal age >35 years, % Newborn DS Terminations Total DS
Australia: Western 25,306 14.95 11.46 11.97 23.43
Australia: Victoria 63,210 17.71 11.35 13.09 24.45
Canada: Alberta 38,019 14.41 13.68 4.11 18.58
Czech Republic 96,158 5.8 6.19 8.81 15.00
England 636,816 14.61 5.63 5.23 10.85
Finland 59,425 17.38 12.08 11.63 23.63
France: Central-East 103,964 15.37 7.39 12.62 20.01
France: Paris 38,878 24.37 7.25 27.09 34.34
France: Strasbourg 13,437 13.3 6.1 13.88 19.89
Italy: Campania 50,574 13.98 6.91 6.11 13.02
Italy: Emilia-Romagna 25,603 18.82 7.88 11.23 19.11
Italy: North-East 55,376 22.83 8.58 7.09 15.67
Italy: Tuscany 24,002 21.52 6.73 9.71 16.48
Israel 20,880 16.36 5.73 3.71 9.43
Mexico 38,508 6.23 11.9 0 11.9
Norway 59,321 13.88 12.45 3.73 17.15
Netherlands: Northern 19,766 14.81 10.64 4.83 15.47
Sweden 98,220 16.04 13.07 9.07 22.12
USA: Atlanta 46,248 14.94 12.66 3.95 16.61
Wales 31,634 13.6 9.72 9.82 19.57
All, 1993 1,554,529 10.89 8.29 4.78 13.08
All, 2004 1,564,501 18.77 8.32 9.92 18.24
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RESULTS
Maternal Age
The percentage of delivering mothers >35 years of age
increased in most registers included in the study (Figs. 1
and 4). The percentage of mothers older than 35 years of
age increased from 10.8% in 1993 to 18.8% in 2004. The
overall percentage for each register is presented in Table
1. The lowest percentage of older mothers was observed
in the Czech Republic (5.8% over the study period, rang-
ing from 4.3% in 1993 to 8.1% in 2004). Mexico had a
similar low percentage of older mothers (6.2%), which
did not change during the study period. The greatest
increase in mothers >35 years of age was observed in
Italy (all four registers combined), where the percentage
increased from 14.5 to 22.7% during the study period. A
similar increase was observed in France, and the Paris
region reported the highest percentage of mothers older
than 35 years of age (28.7% in 2004). Similar increases in
maternal age were reported from the two Australian
registers with 12.9% of the mothers >35 years of age in
1993 compared to 22.4% 2004. There was a much smaller
increase (14.8 to 16.5%, in 1993 and 2004, respectively) in
the percentage of mothers >35 years of age in the mean
of the two registers in North America (Canada Alberta
and USA Atlanta) compared to the European and Austra-
lian registers.
Births with DS
Overall, the mean birth rate with DS remained stable
(8.3/10,000 births) during the study period (Figs. 2 and
4). There were, however, differences between registers. A
marked decrease in DS births was observed in registers
from France and Italy, whereas Canada Alberta, Israel,
and Norway reported an increase in DS births.
ToP with DS
The mean rate of ToP with DS increased from 4.8/
10,000 births in 1993 to 9.9/10,000 births in 2004 (Fig. 4).
The greatest increase was observed in France, especially
in the Paris region (14.8/10,000 in 1993 to 35.7/10,000 in
2004). In the two North American registers (Canada
Alberta and USA Atlanta) the rates of ToP with DS were
low (Fig. 5), and little change was observed during the
study period (3.5 and 3.1/10,000 births in 1993 and 2004,
respectively). The ToP rate in Norway was low compared
to that of the other Nordic countries. The mean gesta-
tional ages at ToP because of DS in mothers >35 years of
age are presented in Table 2 and range from 16.91 week
in Victoria (Australia) to 22.67 weeks in Strasbourg
(France).
Total Prevalence of DS
The total mean prevalence of DS (live and stillbirths
and terminations of pregnancies) increased from 13.1/
10,000 births in 1993 to 18.2/10,000 births in 2004. In 1993
in the European and Australian registers almost two-
thirds of all DS pregnancies resulted in a birth, but in
2004 an opposite trend was seen with two-thirds of DS
Table 2
Mean Gestation Age (Number of Weeks 6 Standard
Deviation) at Time of Termination of Pregnancies with
DS in Women Older than 35 Years of Age in 16
Different Registries in 2002
Monitoring registers Gestational week
(Mean 6 SD)
Australia: Victoria 16.91 6 1.72
Canada: Alberta 18.63 6 2.33
Czech Republic 19.41 6 1.85
Finland 18.00 6 1.36
France: Central-East 19.68 6 2.96
France: Paris 21.25 6 4.75
France: Strasbourg 22.67 6 5.39
Israel: IBDMS 21.50 6 1.38
Italy: BDRCam 20.39 6 2.34
Italy: IMER 21.43 6 1.29
Italy: North-East 19.31 6 1.60
Italy: Tuscany 18.94 6 1.12
Netherlands: Northern 18.25 6 0.96
Sweden 17.19 6 1.48
USA: Atlanta 20.00 6 3.61
Wales 18.53 6 2.23
Figure 1. Mean percentages of mothers 35 years of age in the registers during the period 1993–2004. A: Australia Western, Australia
Victoria, Canada Alberta, Czech Republic, England, Finland. B: France Central East, France Paris, France Strasbourg, Italy Campania,
Italy Emilia-Romagna, Italy North East, Italy Tuscany. C: Israel, Mexico, Netherlands Northern, Norway, Sweden, USA Atlanta.
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pregnancies ending in ToP (Fig. 5). In the North Ameri-
can registers about 3=4 of all DS pregnancies resulted in
birth of a DS child, with little change over time.
DISCUSSION
We found increases in maternal age at birth for most
registers, consistent with the findings of Dolk et al. (2005)
for Europe and Bittles et al. (2006) in Australia. This has
resulted in an increase in pregnancies with DS, but
because of increasing use of different prenatal diagnostic
procedures followed by terminations of DS pregnancies,
overall there has been no change in births of children
with DS. In most registers the increase in DS pregnancies
was balanced by an increase in terminations. However,
in France (also reported by others, such as Khoshnood
et al., 2004, 2008) and Italy, there was a very clear
decrease of DS births.
In the North American registers (Canada Alberta,
Mexico, and USA Atlanta) there was no or very little
increase in mean maternal ages, and terminations of
pregnancies with DS were performed to a lesser degree
than reported from the Australian and European regis-
ters (Stiffel et al., 2004). In the USA an increase in chil-
dren born with DS has been reported (Besser et al., 2007),
and in Victoria, Australia, no change in live-birth preva-
lence has been reported (Collins et al., 2008). In the pres-
ent study an increase in DS births was observed in
Alberta, Canada, Israel, and Norway.
There are great differences in the laws and policies
concerning terminations of pregnancies between coun-
tries (Dolk et al., 2005). Terminations of pregnancies are
allowed to be performed very late in the second trimester
Figure 2. Mean numbers of born children with DS (live-born 1 stillborn)/10,000 births in the registers during the period 1993–2004. A:
Australia Western, Australia Victoria, Canada Alberta, Czech Republic, England, Finland. B: France Central East, France Paris, France
Strasbourg, Italy Campania, Italy Emilia-Romagna, Italy North East, Italy Tuscany. C: Israel, Mexico, Netherlands Northern, Norway,
Sweden, USA Atlanta.
Figure 3. Mean numbers of terminated pregnancies with DS/10,000 births in the registers during the period 1993–2004. A: Australia
Western, Australia Victoria, Canada Alberta, Czech Republic, England, Finland. B: France Central East, France Paris, France Strasbourg,
Italy Campania, Italy Emilia-Romagna, Italy North East, Italy Tuscany. C: Israel, Mexico, Netherlands Northern, Norway, Sweden, USA
Atlanta.
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in some countries (Czech Republic, France, Israel, and
Italy) and not permitted at all in Mexico. These differen-
ces, along with different methods of prenatal screening
and diagnosis, are reflected by differences in gestational
age at the time of terminations of pregnancies with DS
(Table 2). In France and Italy, but also in Israel and USA
Atlanta, the mean gestational age at terminations was
later compared to that of Australia Victoria, Canada
Alberta, Finland, Northern Netherlands, and Sweden.
The implementation of the measurement of nuchal trans-
lucency and maternal serum screening have been an im-
portant factor in the reduction in prevalence of DS births
in France (de Vigan et al., 2008; Goujard, 2007; Kjaers-
gaard et al., 2008). In the study period of this investiga-
tion (1993–2004) these screening methods were not yet
introduced in most of the countries included. In Sweden,
for example, only half of pregnant women were offered
such screening in 2009, and in some countries amniotic
fluid sampling is restricted to older mothers (>37 years
of age in Norway).
All these factors have resulted in differences in the prev-
alence of DS births. Norway with a rather large population
of older mothers and with little use of prenatal diagnostic
procedures has a high rate of children born with DS (17/
10,000 births). France, especially the Paris region, has a
high proportion of older mothers, but the use of prenatal
procedures and terminations of pregnancies are widely
used, which results in one of the lowest prevalence of DS
births combined with the highest rate of ToP with DS.
In spite of similar numbers of mothers older than
35 years of age among registers there was a large varia-
tion in reported cases with DS among the registers. This
raised a suspicion of under-registration. Under-reporting
in the England register has previously been shown (Boyd
et al., 2005). When this register is excluded from the cal-
culations, the total mean of births 1 ToP changed from
13.1 to 16.8/10,000 births in 1993 and from 18.2 to 21.5/
10,000 births in 2004. In addition, we had data on only
the percentage of mothers older than 35 years of age, but
not the exact numbers of mothers in each age group.
Thus we could not evaluate the correct ascertainment
according to the method of Hecht and Hook (1981). In an
ongoing study by Leoncini and co-workers using data
from present registries for the period 2002–2005, the
ascertainment has been calculated using the method of
Hecht and Hook (1981). The under-ascertainment varied
among registers and was in some registers substantial; it
was most likely due to under-reporting of ToP, rather
than births with DS (Leoncini, personal communication).
CONCLUSIONS
Maternal age at delivery has increased in almost all
parts of the western world. In 1993 about 11% of mothers
were older than 35 years of age, and 12 years later it was
about 19%. This resulted in a great increase of pregnan-
cies with DS, but because of increasing use of prenatal
diagnostics procedures and terminations of pregnancies,
the prevalence of DS births remained stable in most
registers. There are, however, differences between the
European and Australian registers compared to the
North American registers, which report fewer termina-
tions of pregnancy with DS and do not show the same
increase in maternal age.
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Figure 4. Mean total trends of percentage mothers older than
35 years of age, born children (live-born and stillborn) with
DS/10,000 births, termination of pregnancies with DS (ToP)/
10,000 births, observed total DS (live-born and stillborn children
1 ToP)/10,000 births for the period 1993–2004.
Figure 5. Mean total numbers live-born and stillborn (gray bars) and terminated pregnancies (white bars) with DS/10,000 births for the
period 1993–2004 in (A) Europe, (B) Australia, and (C) North America.
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